NOD2/CARD15 variants of donor and recipient as critical risk factors for the development of bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.

被引:0
|
作者
Hildebrandt, G
Wolff, D
Hertenstein, B
Greinix, HT
Rogler, G
Brenmoehl, J
Schulz, C
Dickinson, AM
Andreesen, R
Holler, E
机构
[1] Univ Regensburg, Dept Hematol, D-8400 Regensburg, Germany
[2] Univ Rostock, Dept Hematol, Rostock, Germany
[3] Hannnover Med Univ, Dept Hematol, Hannover, Germany
[4] Vienna Med Univ, Dept Internal Med 1, Vienna, Austria
[5] Univ Regensburg, Dept Internal Med, D-8400 Regensburg, Germany
[6] Univ Regensburg, Dept Pulm, D-8400 Regensburg, Germany
[7] Royal Victoria Infirm, Dept Hematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
144
引用
收藏
页码:46A / 46A
页数:1
相关论文
共 50 条
  • [41] NOD2/CARD15 gene mutations and allogeneic stem cell transplantation outcome:: preliminary results of a retrospective single-centre study
    Scimè, R
    Indovina, A
    Renda, MC
    Cavallaro, A
    Tringali, S
    Macaluso, A
    Bruno, G
    Santoro, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S98 - S98
  • [42] Nintedanib in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
    Tang, Wenjiao
    Yu, Ting
    Dong, Tian
    Liu, Ting
    Ji, Jie
    CHEST, 2020, 158 (03) : E89 - E91
  • [43] The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation
    Holler, E.
    Rogler, G.
    Brenmoehl, J.
    Hahn, J.
    Greinix, H.
    Dickinson, A. M.
    Socie, G.
    Wolff, D.
    Finke, J.
    Fischer, G.
    Jackson, G.
    Rocha, V.
    Hilgendorf, I.
    Eissner, G.
    Marienhagen, J.
    Andreesen, R.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2008, 35 (4-5) : 381 - 384
  • [44] Ruxolitinib for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
    Kulagin, Egor A.
    Volkova, Alisa G.
    Dotsenko, Anna A.
    Yanbukhtina, Valeria R.
    Rabik, Julia D.
    Smirnova, Anna G.
    Golubovskaya, Irina K.
    Trofimov, Vasiliy I.
    Moiseev, Ivan S.
    BLOOD, 2021, 138
  • [45] Impact of donor and patient NOD2/CARD 15 polymorphisms in the outcome of unrelated stem cell transplantation
    Vigh, A.
    Putzbach, J.
    Schrezenmeier, H.
    Mytilineos, J.
    TISSUE ANTIGENS, 2008, 71 (04): : 315 - 315
  • [46] NOD2/CARD15 GENETIC VARIANTS ARE ASSOCIATED WITH SUSCEPTIBILITY TO LOFGREN'S SYNDROME IN PATIENTS WITH SARCOIDOSIS
    Bogunia-Kubik, Katarzyna
    Jaskula, Emilia
    Wojtowicz, Agnieszka
    Lange, Andrzej
    TISSUE ANTIGENS, 2012, 79 (06): : 482 - 482
  • [47] Donor and recipient CMV status and the risk of CMV activation after allogeneic stem cell transplantation.
    Juvonen, E
    Ruutu, T
    Eriksson, B
    Remes, K
    Volin, L
    Remberger, M
    Parkkali, T
    Hägglund, H
    Ringdén, O
    BLOOD, 2001, 98 (11) : 396A - 396A
  • [48] SNP 8 in NOD2/CARD15 gene is associated with CMV reactivation after transplantation of hematopoietic stem cells
    Bogunia-Kubik, Katarzyna
    Jaskula, Emilia
    Lange, Andrzej
    TISSUE ANTIGENS, 2010, 75 (05): : 556 - 556
  • [49] Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
    Rhee, Chin Kook
    Ha, Jick Hwan
    Yoon, Jae Ho
    Cho, Byung Sik
    Min, Woo-Sung
    Yoon, Hyoung Kyu
    Lee, Jong Wook
    YONSEI MEDICAL JOURNAL, 2016, 57 (02) : 365 - 372
  • [50] Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation
    Kroshus, TJ
    Kshettry, VR
    Savik, K
    John, R
    Hertz, MI
    Bolman, RM
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 114 (02): : 195 - 202